| Date Filed | Type | Description |
| 12/08/2020 |
4
| Endo International plc (10% Owner) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Bought 7,344,955 shares
@ $88.5, valued at
$650M
|
|
| 12/02/2020 |
4
| Chao Jennifer M (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 1,920 shares
@ $0
Disposed/sold 1,726 shares
@ $0
Disposed/sold 1,687 options to buy
@ $37.64, valued at
$63.5k
Disposed/sold 15,000 options to buy
@ $41.82, valued at
$627.3k
Disposed/sold 5,000 options to buy
@ $55.62, valued at
$278.1k
|
|
| 12/02/2020 |
4
| Wegman Toby (10% Owner) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 1,890 shares
@ $0
Disposed/sold 1,726 shares
@ $0
Disposed/sold 935,073 shares
@ $0 |
|
| 12/02/2020 |
4
| Fishman Corey N. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 2,018 shares
@ $0
Disposed/sold 6,000 options to buy
@ $55.63, valued at
$333.8k
|
|
| 12/02/2020 |
4
| Wegman Mark N (10% Owner) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Gifted 2,400 shares
@ $0
Disposed/sold 64,762 shares
@ $0
Disposed/sold 1,726 shares
@ $0
Disposed/sold 935,073 shares
@ $0 |
|
| 12/02/2020 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 115,890 shares
@ $0
Disposed/sold 1,726 shares
@ $0 |
|
| 12/02/2020 |
4
| Truitt Joseph (CEO) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 100,000 options to buy
@ $63.72, valued at
$6.4M
|
|
| 12/02/2020 |
4
| Gitman Paul (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 16,890 shares
@ $0
Disposed/sold 1,726 shares
@ $0 |
|
| 12/02/2020 |
4
| HUTCHISON PATRICK (CFO) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 10,000 options to buy
@ $56.21, valued at
$562.1k
|
|
| 12/02/2020 |
4
| Sherman Michael A. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 2,018 shares
@ $0
Disposed/sold 6,000 options to buy
@ $55.63, valued at
$333.8k
|
|
| 10/29/2020 |
3
| Endo International plc (See footnotes (1)(2)(3)(4)) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 10/19/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/17/2020 |
4
| Gitman Paul (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,726 shares
@ $0 |
|
| 07/17/2020 |
4
| Wegman Toby (10% Owner) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,726 shares
@ $0 |
|
| 07/17/2020 |
4
| Chao Jennifer M (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,726 shares
@ $0 |
|
| 07/17/2020 |
4
| Wegman Mark N (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,726 shares
@ $0 |
|
| 07/17/2020 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,726 shares
@ $0 |
|
| 05/29/2020 |
4
| Truitt Joseph (CEO) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 130,000 options to buy
@ $63.72, valued at
$8.3M
|
|
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Sherman Michael A. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 6,000 options to buy
@ $55.63, valued at
$333.8k
|
|
| 04/15/2020 |
4
| Fishman Corey N. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 2,018 shares
@ $0 |
|
| 04/15/2020 |
4
| Sherman Michael A. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 2,018 shares
@ $0 |
|
| 04/15/2020 |
3
| Sherman Michael A. (Director) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 04/15/2020 |
3
| Truitt Joseph (See Remarks) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 04/15/2020 |
3
| Fishman Corey N. (Director) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| HUTCHISON PATRICK (CFO) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $56.21, valued at
$562.1k
|
|
| 01/10/2020 |
3
| HUTCHISON PATRICK (CFO) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 11/22/2019 |
4
| CALDWELL PATRICK M (Principal Financial Officer) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 500 shares
@ $0 |
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
3
| BUCHI J KEVIN (CEO) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 09/10/2019 |
4
| Wegman Toby (10% Owner) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 1,100 shares
@ $55.23, valued at
$60.8k
Sold 8,900 shares
@ $55.16, valued at
$490.9k
|
|
| 09/06/2019 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 15,000 options to buy
@ $26.43, valued at
$396.5k
|
|
| 07/10/2019 |
4/A
| Wegman Mark N (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,890 shares
@ $0 |
|
|